Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works

Published:January 07, 2019DOI:https://doi.org/10.1016/j.jhin.2018.12.020

      Summary

      The association between healthcare-associated invasive aspergillosis and hospital construction/building works is well recognized. This infection can cause significant morbidity and mortality and imposes a substantial burden on the healthcare system. The population of patients at risk for this opportunistic infection has expanded and multi-triazole drug resistance has emerged globally. Hence the need for a multi-faceted approach to prevent acquisition of invasive aspergillosis in acute care settings. This article is a summary of the Irish National Guidelines for the prevention of healthcare-associated aspergillosis which is based on published reports, international clinical guidelines, official engineering standards, and technical guidelines. We discuss the key recommendations and strategies for the prevention of invasive aspergillosis from the planning/pre-construction, construction, and post-construction phases. The importance of multi-disciplinary team involvement, education, and communication is emphasized.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Garnaud C.
        • Brenier-Pinchart M.-P.
        • Thiebaut-Bertrand A.
        • Hamidfar R.
        • Quesada J.-L.
        • Bosseray A.
        • et al.
        Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital.
        J Infect. 2012; 65: 559-567
        • Graf K.
        • Khani S.M.
        • Ott E.
        • Mattner F.
        • Gastmeier P.
        • Sohr D.
        • et al.
        Five-years surveillance of invasive aspergillosis in a university hospital.
        BMC Infect Dis. 2011; 11: 163
        • Stevens D.A.
        • Melikian G.L.
        Aspergillosis in the “nonimmunocompromised” host.
        Immunol Invest. 2011; 40: 751-766
        • Haiduven D.
        Nosocomial aspergillosis and building construction.
        Med Mycol. 2009; 47: 210-216
        • Suleyman G.
        • Alangaden G.J.
        Nosocomial fungal infections: epidemiology, infection control, and prevention.
        Infect Dis Clin North Am. 2016; 30: 1023-1052
        • Partridge-Hinckley K.
        • Liddell G.M.
        • Almyroudis N.G.
        • Segal B.H.
        Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients.
        Mycopathologia. 2009; 168: 329-337
        • Lavergne R.-A.
        • Chouaki T.
        • Hagen F.
        • Toublanc B.
        • Dupont H.
        • Jounieaux V.
        • et al.
        Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients.
        Clin Infect Dis. 2017; 64: 76-78
        • Schweer K.
        • Jakob B.
        • Liss B.
        • Christ H.
        • Fischer G.
        • Vehreschild M.
        • et al.
        Domestic mould exposure and invasive aspergillosis – air sampling of Aspergillus spp. spores in homes of hematological patients, a pilot study.
        Med Mycol. 2016; 54: 576-583
        • Aspergillosis Subcommittee of the Health Protection Surveillance Centre Scientific Advisory Committee
        National guidelines for the prevention of nosocominal aspergillosis.
        2018 (Available at:) ([last accessed September 2018])
        • Tilton R.C.
        • McGinnis M.R.
        Opportunistic fungi.
        in: Howard B.J. Clinical and pathogenic microbiology. CV Mosby, St Louis, MO1987: 609-623
        • Samson R.A.
        • Varga J.D.P.
        Morphology and reproductive mode of Aspergillus fumigatus and aspergillosis.
        in: Latge J.P. Steinbach W.J. Aspergillus fumigatus. ASM Press, Washington DC2009: 7-13
        • Rotstein C.
        • Cummings K.M.
        • Tidings J.
        • Killion K.
        • Powell E.
        • Gustafson T.L.
        • et al.
        An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case–control study.
        Infect Control. 1985; 6: 347-355
        • Perraud M.
        • Piens M.A.
        • Nicoloyannis N.
        • Girard P.
        • Sepetjan M.
        • Garin J.P.
        Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works.
        Epidemiol Infect. 1987; 99: 407-412
        • Anderson K.
        • Morris G.
        • Kennedy H.
        • Croall J.
        • Michie J.
        • Richardson M.D.
        • et al.
        Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air.
        Thorax. 1996; 51: 256-261
        • Oren I.
        • Haddad N.
        • Finkelstein R.
        • Rowe J.M.
        Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
        Am J Hematol. 2001; 66: 257-262
        • Vonberg R.P.
        • Gastmeier P.
        Nosocomial aspergillosis in outbreak settings.
        J Hosp Infect. 2006; 63: 246-254
        • Chang C.C.
        • Cheng A.C.
        • Devitt B.
        • Hughes A.J.
        • Campbell P.
        • Styles K.
        • et al.
        Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
        J Hosp Infect. 2008; 69: 33-38
        • Steinbach W.J.
        • Marr K.A.
        • Anaissie E.J.
        • Azie N.
        • Quan S.P.
        • Meier-Kriesche U.
        • et al.
        Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.
        J Infect. 2012; 65: 453-464
        • Meersseman W.
        • Vandecasteele S.J.
        • Wilmer A.
        • Verbeken E.
        • Peetermans W.E.
        • Van Wijngaerden E.
        Invasive aspergillosis in critically ill patients without malignancy.
        Am J Respir Crit Care Med. 2004; 170: 621-625
        • Meersseman W.
        • Lagrou K.
        • Maertens J.
        • Van Wijngaerden E.
        Invasive aspergillosis in the intensive care unit.
        Clin Infect Dis. 2007; 45: 205-216
        • Guinea J.
        • Torres-Narbona M.
        • Gijon P.
        • Munoz P.
        • Pozo F.
        • Pelaez T.
        • et al.
        Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.
        Clin Microbiol Infect. 2010; 16: 870-877
        • Espinel-Ingroff A.
        • Arendrup M.C.
        • Pfaller M.A.
        • Bonfietti L.X.
        • Bustamante B.
        • Canton E.
        • et al.
        Interlaboratory variability of caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?.
        Antimicrob Agents Chemother. 2013; 57: 5836-5842
        • Pelaez T.
        • Munoz P.
        • Guinea J.
        • Valerio M.
        • Giannella M.
        • Klaassen C.H.W.
        • et al.
        Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
        Clin Infect Dis. 2012; 54: e24-e31
        • Wessolossky M.
        • Welch V.L.
        • Sen A.
        • Babu T.M.
        • Luke D.R.
        Invasive aspergillus infections in hospitalized patients with chronic lung disease.
        Infect Drug Resist. 2013; 6: 33-39
        • Baddley J.W.
        • Stephens J.M.
        • Ji X.
        • Gao X.
        • Schlamm H.T.
        • Tarallo M.
        Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes.
        BMC Infect Dis. 2013; 13: 29
        • van de Veerdonk F.L.
        • Kolwijck E.
        • Lestrade P.P.
        • Hodiamont C.J.
        • Rijnders B.J.
        • van Paassen J.
        • et al.
        Influenza-associated aspergillosis in critically ill patients.
        Am J Respir Crit Care Med. 2017 Apr 7; ([Epub ahead of print])
        • Schauwvlieghe A.F.A.D.
        • Rijnders B.J.A.
        • Philips N.
        • Verwijs R.
        • Vanderbeke L.
        • Van Tienen C.
        • et al.
        Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
        Lancet Respir Med. 2018; 6: 782-792
        • Sherif R.
        • Segal B.H.
        Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
        Curr Opin Pulm Med. 2010; 16: 242-250
        • Upton A.
        • Kirby K.A.
        • Carpenter P.
        • Boeckh M.
        • Marr K.A.
        Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
        Clin Infect Dis. 2007; 44: 531-540
        • Mayr A.
        • Lass-Flörl C.
        Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.
        Eur J Med Res. 2011; 16: 153-157
        • Rhame F.S.
        Prevention of nosocomial aspergillosis.
        J Hosp Infect. 1991; 18: 466-472
        • Hansen D.
        • Blahout B.
        • Benner D.
        • Popp W.
        Environmental sampling of particulate matter and fungal spores during demolition of a building on a hospital area.
        J Hosp Infect. 2008; 70: 259-264
        • Walsh T.J.
        • Dixon D.M.
        Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment.
        Eur J Epidemiol. 1989; 5: 131-142
        • Rhame F.S.
        • Streifel A.J.
        • Kersey J.H.
        • McGlave P.B.
        Extrinsic risk factors for pneumonia in the patient at high risk of infection.
        Am J Med. 1984; 76: 42-52
        • Weber D.J.
        • Peppercorn A.
        • Miller M.B.
        • Sickbert-Benett E.
        • Rutala W.A.
        Preventing healthcare-associated aspergillus infections: review of recent CDC/HICPAC recommendations.
        Med Mycol. 2009; 47: S199-S209
        • Kanamori H.
        • Rutala W.A.
        • Sickbert-Bennett E.E.
        • Weber D.J.
        Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation.
        Clin Infect Dis. 2015; 61: 433-444
        • Shoham S.
        • Marr K.A.
        Invasive fungal infections in solid organ transplant recipients.
        Future Microbiol. 2012; 7: 639-655
        • Pagano L.
        • Akova M.
        • Dimopoulos G.
        • Herbrecht R.
        • Drgona L.
        • Blijlevens N.
        Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.
        J Antimicrob Chemother. 2011; 66: i5-i14
        • Neofytos D.
        • Treadway S.
        • Ostrander D.
        • Alonso C.D.
        • Dierberg K.L.
        • Nussenblatt V.
        • et al.
        Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.
        Transpl Infect Dis. 2013; 15: 233-242
        • Lortholary O.
        • Gangneux J.P.
        • Sitbon K.
        • Lebeau B.
        • de Monbrison F.
        • Le Strat Y.
        • et al.
        Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007).
        Clin Microbiol Infect. 2011; 17: 1882-1889
        • Panackal A.A.
        • Li H.
        • Kontoyiannis D.P.
        • Mori M.
        • Perego C.A.
        • Boeckh M.
        • et al.
        Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation.
        Clin Infect Dis. 2010; 50: 1588-1597
        • Rubio P.M.
        • Sevilla J.
        • González-Vicent M.
        • Lassaletta A.
        • Cuenca-Estrella M.
        • Díaz M.A.
        • et al.
        Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
        J Pediatr Hematol Oncol. 2009; 31: 642-646
        • Mikulska M.
        • Raiola A.M.
        • Bruno B.
        • Furfaro E.
        • Van Lint M.T.
        • Bregante S.
        • et al.
        Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
        Bone Marrow Transplant. 2009; 44: 361-370
        • Carvalho-Dias V.M.H.
        • Sola C.B.S.
        • Cunha CA da
        • Shimakura S.E.
        • Pasquini R.
        • Queiroz-Telles F de
        Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis.
        Braz J Infect Dis. 2008; 12: 385-389
        • Garcia-Vidal C.
        • Upton A.
        • Kirby K.A.
        • Marr K.A.
        Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation.
        Clin Infect Dis. 2008; 47: 1041-1050
        • Morgan J.
        • Wannemuehler K.A.
        • Marr K.A.
        • Hadley S.
        • Kontoyiannis D.P.
        • Walsh T.J.
        • et al.
        Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.
        Med Mycol. 2005; 43: S49-S58
        • Marr K.A.
        • Carter R.A.
        • Boeckh M.
        • Martin P.
        • Corey L.
        Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
        Blood. 2002; 100: 4358-4366
        • Peppel RJ Van De
        • Visser L.G.
        • Dekkers O.M.
        • Boer MGJ De
        The burden of invasive aspergillosis in patients with haematological malignancy: a meta-analysis and systematic review.
        J Infect. 2018; 76: 550-562
        • Pinney M.F.
        • Rosenberg A.F.
        • Hampp C.
        • Schain D.
        • Akindipe O.
        • Baz M.
        Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
        Pharmacotherapy. 2011; 31: 537-545
        • Pasqualotto A.C.
        • Xavier M.O.
        • Sánchez L.B.
        • de Oliveira Costa C.D.A.
        • Schio S.M.
        • Camargo S.M.
        • et al.
        Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
        Transplantation. 2010; 90: 306-311
        • Iversen M.
        • Burton C.M.
        • Vand S.
        • Skovfoged L.
        • Carlsen J.
        • Milman N.
        • et al.
        Aspergillus infection in lung transplant patients: incidence and prognosis.
        Eur J Clin Microbiol Infect Dis. 2007; 26: 879-886
        • Raviv Y.
        • Kramer M.R.
        • Amital A.
        • Rubinovitch B.
        • Bishara J.
        • Shitrit D.
        Outbreak of aspergillosis infections among lung transplant recipients.
        Transpl Int. 2007; 20: 135-140
        • Solé A.
        • Morant P.
        • Salavert M.
        • Pemán J.
        • Morales P.
        • Valencia Lung Transplant Group
        Aspergillus infections in lung transplant recipients: risk factors and outcome.
        Clin Microbiol Infect. 2005; 11: 359-365
        • Singh N.
        • Husain S.
        Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.
        J Heart Lung Transplant. 2003; 22: 258-266
        • Minari A.
        • Husni R.
        • Avery R.K.
        • Longworth D.L.
        • DeCamp M.
        • Bertin M.
        • et al.
        The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
        Transpl Infect Dis. 2002; 4: 195-200
        • Pacholczyk M.
        • Lagiewska B.
        • Lisik W.
        • Wasiak D.
        • Chmura A.
        Invasive fungal infections following liver transplantation – risk factors, incidence and outcome.
        Ann Transplant. 2011; 16: 14-16
        • Ju M.K.
        • Joo D.J.
        • Kim S.J.
        • Chang H.K.
        • Kim M.S.
        • Kim S.I.
        • et al.
        Invasive pulmonary aspergillosis after solid organ transplantation: diagnosis and treatment based on 28 years of transplantation experience.
        Transplant Proc. 2009; 41: 375-378
        • Sharifipour F.
        • Rezaeetalab F.
        • Naghibi M.
        Pulmonary fungal infections in kidney transplant recipients: an 8-year study.
        Transplant Proc. 2009; 41: 1654-1656
        • Einollahi B.
        • Lessan-Pezeshki M.
        • Pourfarziani V.
        • Nemati E.
        • Nafar M.
        • Pour-Reza-Gholi F.
        • et al.
        Invasive fungal infections following renal transplantation: a review of 2410 recipients.
        Ann Transplant. 2008; 13: 55-58
        • Aubron C.
        • Pilcher D.
        • Leong T.
        • Cooper D.J.
        • Scheinkestel C.
        • Pellegrino V.
        • et al.
        Aspergillus sp. isolated in critically ill patients with extracorporeal membrane oxygenation support.
        Scand J Infect Dis. 2013; 45: 715-721
        • De Pauw B.
        • Walsh T.J.
        • Donnelly J.P.
        • Stevens D.A.
        • Edwards J.E.
        • Calandra T.
        • et al.
        Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C.
        Clin Infect Dis. 2008; 46: 1813-1821
        • Chang C.C.
        • Ananda-Rajah M.
        • Belcastro A.
        • Mcmullan B.
        • Reid A.
        • Dempsey K.
        • et al.
        Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works.
        Intern Med J. 2014; 44 (2014): 1389-1397
        • Centers for Disease Control and Prevention, Infectious Disease Society of America
        American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
        Morb Mortal Wkly Rep. 2000; 49 (CE1-7): 1-125
        • Sehulster L.
        • Chinn R.Y.W.
        • CDC
        • HICPAC
        Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
        Morb Mortal Wkly Rep. 2003; 52: 1-42
        • SF2H-SFMM
        Risk of fungal infections, and construction work in hospitals.
        2011 (Available at:) ([last accessed May 2018])
      1. Health Building Note 00-09: Infection control in the built environment. 2012 (Available at:) ([last accessed January 2019])
      2. US Centers for Disease Control. Guidelines for environmental infection control in health-care facilities recommendations of CDC and the healthcare infection control practices advisory committee (HICPAC). n.d.

        • Bartley J.
        Infection control risk assessment matrix of precautions for construction & renovation.
        Construction. 2009; : 1-5
        • Morris G.
        • Kokki M.H.
        • Anderson K.
        • Richardson M.D.
        Sampling of Aspergillus spores in air.
        J Hosp Infect. 2000; 44: 81-92
        • Reboux G.
        • Gbaguidi-Haore H.
        • Bellanger A.P.
        • Demonmerot F.
        • Houdrouge K.
        • Deconinck E.
        • et al.
        A 10-year survey of fungal aerocontamination in hospital corridors: a reliable sentinel to predict fungal exposure risk?.
        J Hosp Infect. 2014; 87: 34-40
        • Rogers T.R.
        • Slavin M.A.
        • Donnelly J.P.
        Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?.
        Br J Haematol. 2011; 153: 681-697
        • Ziakas P.D.
        • Kourbeti I.S.
        • Mylonakis E.
        Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
        Clin Ther. 2014; 36: 292-306.e1
        • Maertens J.A.
        • Girmenia C.
        • Brüggemann R.J.
        • Duarte R.F.
        • Kibbler C.C.
        • Ljungman P.
        • et al.
        European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
        J Antimicrob Chemother. 2018; 73: 3221-3230
      3. Patterson TF, Thompson III GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America.

        • Ullmann A.J.
        • Aguado J.M.
        • Arikan-Akdagli S.
        • Denning D.W.
        • Groll A.H.
        • Lagrou K.
        • et al.
        Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
        Clin Microbiol Infect. 2018; 24: e1-e38
        • Singh N.
        • Husain S.
        Aspergillosis in solid organ transplantation infectious diseases community of practice.
        Am J Transplant. 2013; 13 ([Erratum in: Am J Transplant 2013;13:1621.]): 228-241
        • Muñoz P.
        • Valerio M.
        • Palomo J.
        • Giannella M.
        • Yañez J.F.
        • Desco M.
        • et al.
        Targeted antifungal prophylaxis in heart transplant recipients.
        Transplantation. 2013; 96: 664-669
        • Chabrol A.
        • Cuzin L.
        • Huguet F.
        • Alvarez M.
        • Verdeil X.
        • Linas M.D.
        • et al.
        Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
        Haematologica. 2010; 95: 996-1003
        • Chang C.C.
        • Cheng A.C.
        • Devitt B.
        • Hughes A.J.
        • Campbell P.
        • Styles K.
        • et al.
        Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
        J Hosp Infect. 2008; 69: 33-38
        • Combariza J.F.
        • Toro L.F.
        • Orozco J.J.
        Effectiveness of environmental control measures to decrease the risk of invasive aspergillosis in acute leukaemia patients during hospital building work.
        J Hosp Infect. 2017; 96: 336-341
        • Combariza J.F.
        • Toro L.F.
        • Orozco J.J.
        • Arango M.
        Cost-effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities.
        Eur J Haematol. 2018; 100: 140-146
        • Ashbee H.R.
        • Barnes R.A.
        • Johnson E.M.
        • Richardson M.D.
        • Gorton R.
        • Hope W.W.
        Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.
        J Antimicrob Chemother. 2014; 69: 1162-1176
        • Verweij P.E.
        • Ananda-Rajah M.
        • Andes D.
        • Arendrup M.C.
        • Bruggemann R.J.
        • Chowdhary A.
        • et al.
        International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
        Drug Resist Updat. 2015; 21–22: 30-40
        • Wirmann L.
        • Ross B.
        • Reimann O.
        • Steinmann J.
        • Rath P.-M.
        Airborne Aspergillus fumigatus spore concentration during demolition of a building on a hospital area and patient risk determination for invasive aspergillosis including azole resistance.
        J Hosp Infect. 2018; 100: e91-e97
      4. Heating and ventilation systems Health Technical Memorandum 03-01: Specialised ventilation for healthcare premises Part B. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/144030/HTM_03-01_Part_B.pdf [last accessed May 2018].

      5. Heating and ventilation systems Health Technical Memorandum 03-01: Specialised ventilation for healthcare premises Part A. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/144029/HTM_03-01_Part_A.pdf [last accessed May 2018].

        • Health Building Note 04-01 Supplement 1
        Isolation facilities for infectious patients in acute settings.
        2013 (Available at:) ([last accessed November 2018])
        • Department of Health UK
        Health building note 04-01, supplement 1. Isolation facilities in acute settings.
        2005
        • Loschi M.
        • Thill C.
        • Gray C.
        • David M.
        • Bagatha M.F.
        • Chamseddine A.
        • et al.
        Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients.
        Mycopathologia. 2015; 179: 337-345
        • Pilmis B.
        • Thepot-Seegers V.
        • Angebault C.
        • Weiss E.
        • Alaabouche I.
        • Bougnoux M.E.
        • et al.
        Could we predict airborne Aspergillus contamination during construction work?.
        Am J Infect Control. 2017; 45: 39-41
        • Barreiros G.
        • Akiti T.
        • Magalhães A.C.G.
        • Nouér S.A.
        • Nucci M.
        Effect of the implosion and demolition of a hospital building on the concentration of fungi in the air.
        Mycoses. 2015; 58: 707-713
        • Eckmanns T.
        • Rüden H.
        • Gastmeier P.
        The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review.
        J Infect Dis. 2006; 193: 1408-1418
        • Tomblyn M.
        • Chiller T.
        • Einsele H.
        • Gress R.
        • Sepkowitz K.
        • Storek J.
        • et al.
        Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.
        Biol Blood Marrow Transplant. 2009; 15: 1143-1238
        • Humphreys H.
        Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence?.
        J Hosp Infect. 2004; 56: 93-100
        • Ryan L.
        • O’Mara N.
        • Tansey S.
        • Slattery T.
        • Hanahoe B.
        • Vellinga A.
        • et al.
        A 2-year comparative study of mold and bacterial counts in air samples from neutral and positive pressure rooms in 2 tertiary care hospitals.
        Am J Infect Control. 2018; 46: 590-593
        • Blot S.I.
        • Taccone F.S.
        • Van Den Abeele A.M.
        • Bulpa P.
        • Meersseman W.
        • Brusselaers N.
        • et al.
        A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.
        Am J Respir Crit Care Med. 2012; 186: 56-64
        • Bulpa P.
        • Dive A.
        • Sibille Y.
        Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.
        Eur Respir J. 2007; 30: 782-800
        • Kaya H.
        • Ozaki J.
        • Okumura H.
        Usefulness of galactomannan antigen testing and the prediction of an outbreak during hospital reconstruction.
        Intern Med. 2018; 57: 1983-1988
        • Guinea J.
        • Garcia de Viedma D.
        • Pelaez T.
        • Escribano P.
        • Munoz P.
        • Meis J.F.
        • et al.
        Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis.
        J Clin Microbiol. 2011; 49: 3498-3503
        • Loeffert S.T.
        • Melloul E.
        • Gustin M.-P.
        • Hénaff L.
        • Guillot C.
        • Dupont D.
        • et al.
        Investigation of the relationships between clinical and environmental isolates of Aspergillus fumigatus by multiple-locus variable number tandem repeat analysis during major demolition work in a French hospital.
        Clin Infect Dis. 2019; 68: 321-329
        • Kidd S.E.
        • Ling L.M.
        • Meyer W.
        • Morrissey C.O.
        • Chen S.C.A.
        • Slavin M.A.
        Molecular epidemiology of invasive aspergillosis: lessons learned from an outbreak investigation in an Australian hematology unit.
        Infect Control Hosp Epidemiol. 2009; 30: 1223-1226
      6. EN 13053:2006+A1:2011. Ventilation for buildings. Air handling units. Rating and performance for units, components and sections. Available at: https://standards.cen.eu/dyn/www/f?p=204:110:0::::FSP_PROJECT,FSP_ORG_ID:36865,6138&cs=195B5AEFB475F05C00EECDC4483B32A50 [last accessed May 2018].

      7. EN 1886:2007. Ventilation for buildings. Air handling units. Mechanical performance. Available at: https://standards.cen.eu/dyn/www/f?p=204:110:0::::FSP_PROJECT,FSP_ORG_ID:21763,6138&cs=1F3A95F1A7AEA000F529FC0463D7E7177 [last accessed May 2018].